Future research on ASCT2 will likely focus on developing more selective and potent inhibitors, understanding the mechanisms of resistance, and identifying biomarkers that predict response to ASCT2-targeted therapies. Additionally, exploring the role of ASCT2 in the tumor microenvironment and its interactions with other metabolic pathways will provide deeper insights into its function and therapeutic potential in cancer.